influenza
viral
infect
respiratori
tract
infect
normal
confin
upper
respiratori
tract
certain
viral
strain
evolv
abil
infect
lower
respiratori
tract
includ
alveoli
lead
inflamm
diseas
pattern
diffus
alveolar
damag
factor
lead
sequenc
event
novel
influenza
strain
strain
viral
protein
particular
protein
allow
escap
innat
immun
system
three
main
barrier
prevent
infect
pneumocyt
mucin
host
defenc
lectin
cell
macrophag
virus
develop
strategi
neuraminidas
glycosyl
pattern
allow
evas
though
much
invest
antivir
drug
propos
attent
direct
toward
develop
util
compound
enhanc
abil
innat
immun
system
combat
viral
infect
good
year
europ
final
throe
war
extract
heavi
econom
physic
burden
societi
tremend
loss
life
also
emerg
new
form
respiratori
infect
result
mortal
doctor
europ
unit
state
battl
comprehend
emerg
infect
spread
around
militari
barrack
popul
transmiss
human
human
seen
research
unit
state
unit
kingdom
examin
lung
young
soldier
die
within
day
contact
diseas
found
chang
lung
typifi
appear
noncellular
homogen
exud
eosinophil
thought
due
presenc
albumin
come
comparison
diseas
could
compar
poison
due
chlorin
ga
know
agent
produc
diseas
influenza
viru
like
avian
origin
chang
seen
repres
pictur
diffus
alveolar
damag
even
discoveri
influenza
viru
much
interest
patholog
point
view
viru
led
death
pandem
limit
autopsi
biopsi
patholog
indic
bronchiti
common
present
primari
viral
pneumonia
mainli
seen
young
patient
often
preexist
diseas
mitral
stenosi
vaccin
intens
care
artifici
ventil
readili
avail
overal
pictur
younger
patient
possibl
without
prior
viru
exposur
succumb
fatal
viral
pneumonia
within
number
day
older
subject
develop
bronchiti
even
advent
immunohistochemistri
identifi
viral
antigen
biopsi
autopsi
tissu
necrot
bronchiti
seen
antigen
normal
present
alveoli
emerg
isol
case
pandem
demonstr
crucial
factor
understand
influenza
pathogenesi
fatal
case
pandem
larg
number
influenza
antigen
posit
cell
present
lung
fatal
case
contrast
patient
die
rare
abund
number
antigen
posit
cell
even
though
chang
diffus
alveolar
damag
dad
present
sinc
latter
group
patient
die
antivir
intens
care
therapi
pictur
similar
seen
sar
acut
viral
induc
diseas
antigen
present
follow
second
phase
dad
antigen
identifi
evolv
process
alveolar
destruct
follow
repair
commenc
discuss
becom
clear
sever
pulmonari
burden
occur
bodi
expos
viral
agent
preexist
immun
activ
viral
replic
occur
first
day
follow
prolong
virusfre
exud
phase
pattern
appear
similar
mani
viral
pneumon
pictur
orchestr
action
innat
immun
defenc
system
interact
influenza
innat
immun
defenc
system
mechan
occur
broadli
phase
first
circumvent
natur
extracellular
host
barrier
second
hijack
intracellular
pathway
viru
order
prevent
antivir
respons
direct
cellular
machineri
toward
replic
viral
progeni
three
barrier
influenza
need
defeat
order
success
infect
epitheli
cell
mucin
host
defenc
lectin
alveolar
macrophag
key
factor
influenza
viru
allow
escap
natur
defenc
mechan
surfac
protein
haemagglutinin
ha
neuraminidas
na
first
protein
call
haemagglutinin
studi
hirst
demonstr
influenza
viru
abl
caus
haemagglutin
red
blood
cell
studi
blixt
colleagu
identifi
compon
red
blood
cell
interact
ha
call
sialic
acid
sia
sia
name
given
nonuloson
carbohydr
neuramin
acid
neu
contain
acetyl
group
fifth
carbon
posit
henc
mani
anim
speci
acetyl
group
also
undergo
enzymat
transform
form
glycolyl
group
human
lack
enzym
perform
transform
howev
small
amount
may
incorpor
human
diet
second
key
factor
allow
viral
infect
presenc
na
enzym
abl
cleav
sia
adjac
sugar
often
galactos
gal
viral
na
howev
cleav
sia
equal
strain
prefer
cleav
sia
link
gal
configur
call
sia
review
air
insid
cell
intern
gene
protein
come
play
play
domin
role
ha
na
two
semin
studi
paulson
colleagu
demonstr
key
determin
siaha
interact
first
virus
isol
differ
anim
speci
differ
abil
caus
haemagglutin
virus
isol
human
swine
prefer
agglutin
cell
contain
siagal
linkag
virus
hors
avian
sourc
use
prefer
agglutin
linkag
second
key
find
use
plant
lectin
discriminatori
bind
differ
siagal
interact
lectin
elderberri
bush
sambuccu
nigra
sna
bound
wherea
lectin
bark
maackia
amurensi
maa
preferenti
bound
glycan
lectin
use
bind
human
respiratori
tract
demonstr
ciliat
cell
target
influenza
bound
mainli
sna
indic
abund
goblet
cell
bound
mainli
maa
indic
mainli
put
find
togeth
hypothes
avian
virus
mainli
agglutin
red
blood
cell
would
readili
infect
human
target
cell
mainli
demonstr
sna
bind
scholtissek
propos
swine
could
act
intermedi
host
lectin
bind
ito
colleagu
infer
swine
respiratori
tract
bind
sna
maa
thu
potenti
act
mix
vessel
recent
lectin
bind
studi
exvivo
infect
van
pouck
colleagu
howev
shown
may
variat
swine
respiratori
tract
previous
demonstr
mucu
present
airway
mixtur
cell
cellular
debri
polypetpid
held
togeth
macromolecular
consitu
call
mucin
either
fluid
surfac
cell
mucin
homogen
protein
famili
glycoprotein
may
either
secret
membran
associ
may
function
cellular
receptor
number
excel
review
differ
type
mucin
avail
first
set
mucin
normal
secret
goblet
cell
surfac
epithelium
submuc
gland
present
trachea
bronchi
membran
associ
mucin
present
apic
surfac
ciliat
cell
fig
effect
mucin
influenza
viru
replic
initi
investig
lectin
bind
studi
baum
paulson
loguidic
colleagu
suggest
mucin
mainli
sialyl
keep
mass
spectrograph
data
determin
oglycan
compon
mucin
nichol
et
el
unpublish
result
mucin
therefor
may
trap
avian
influenza
virus
affin
howev
success
abil
influenza
infect
respiratori
epithelium
like
due
prefer
viral
na
cleav
linkag
compar
linkag
mucin
highli
sialyl
acid
natur
sia
result
entrap
water
give
viscou
gel
like
qualiti
mucin
act
physic
barrier
infect
children
fewer
number
submuc
gland
goblet
cell
adult
reduct
number
quantiti
may
suscept
avain
viru
infect
compar
adult
popul
function
unit
lung
alveolu
involv
ga
exchang
achiev
function
requir
narrow
thick
possibl
effici
ga
exchang
thu
presenc
mucin
environ
would
disadvantag
would
creat
barrier
ga
exchang
bodi
howev
anoth
line
defenc
replac
mucin
compound
call
lectin
protein
bind
specif
carbohydr
structur
review
ng
colleagu
influenza
ha
na
glycoprotein
undergo
process
call
glycosyl
mean
glycan
ad
asn
residu
sequenc
asnxserthr
x
amino
acid
except
prolin
normal
glycosyl
pathway
nglycan
cap
sia
howev
owe
action
viral
na
influenza
sialyl
expos
galactos
glycosyl
ha
import
develop
antigen
variat
also
play
role
recognit
host
lectin
mechan
read
colleagu
show
degre
glycosyl
affect
abil
certain
virus
replic
respiratori
tract
mice
virus
lack
glycosyl
ha
abl
caus
diseas
mice
virus
glycosyl
three
class
lectin
demonstr
show
antiinfluenza
activ
ctype
lectin
stype
lectin
pentraxin
review
ng
colleagu
first
type
clectin
calcium
depend
ctype
recogn
mannos
galactos
ctype
lectin
subgroup
call
collectin
collagen
domain
collectin
trimer
compos
polypeptid
carbohydr
recognit
domain
lung
main
lectin
involv
antiinfluenza
activ
surfact
protein
collectin
differ
mechan
spa
sialyl
act
decoy
receptor
call
thu
abil
prevent
influenza
infect
depend
degre
ha
glycosyl
contrast
spd
bind
mannos
type
oligosaccharid
demonstr
interact
influenza
viru
ha
involv
haemagglutin
inhibit
also
abl
mediat
aggreg
viral
particl
inhibit
ha
activ
interact
viral
ha
na
fig
sinc
spd
interact
mannos
antivir
effect
depend
degre
glycosyl
present
thu
chang
ha
associ
drift
due
increas
glycosyl
lead
greater
neutral
spd
thu
reduc
virul
influenc
spd
innat
immun
respons
studi
spd
defici
mice
show
enhanc
viral
replic
glycosyl
influenza
viru
chang
rectifi
overexpress
wild
type
spd
protein
read
colleagu
shown
elev
glucos
interact
spd
result
sever
diseas
diabet
mice
find
note
found
patient
diabet
obes
prone
develop
sever
diseas
pandem
third
lectin
involv
innat
immun
respons
mannos
bind
lectin
mbl
ad
effect
interact
complement
pathway
lead
lysi
phagocytosi
one
histolog
featur
seen
patient
increas
number
macrophag
alveolar
space
studi
ex
vivo
tissu
infect
shown
posit
antigen
cell
unlik
differ
type
epitheli
cell
present
bronchu
alveolar
macrophag
appear
equal
suscept
human
avian
influenza
viru
infect
though
show
less
product
replic
alveolar
macrophag
bone
marrow
deriv
macrophag
macrophag
receptor
mannos
galactos
mmr
mgl
interact
sia
independ
influenza
infect
appear
differ
alveolar
macrophag
compar
bone
marrow
deriv
macrophag
extrapol
studi
use
latter
real
clinic
pictur
interpret
caution
low
number
alveoli
normal
lung
first
respond
recruit
area
influenza
infect
experiment
infect
neutrophil
result
increas
matrix
gene
found
infect
chan
rwi
person
commun
compar
macrophag
cell
type
investig
much
detail
requir
investig
similar
neutrophil
cell
constitut
major
popul
inflammatori
cell
within
normal
alveoli
electron
micrograph
human
ex
vivo
tissu
infect
avian
influenza
viru
show
egress
viral
particl
type
pneumocyt
viral
rna
bind
rigi
ubiquitin
allow
bind
mav
follow
activ
ikk
pathway
transcript
interferon
releas
interferon
lead
increas
cytokin
product
recruit
neutrophil
activ
macrophag
interferon
act
autocrin
paracrin
function
lead
cytokin
antivir
protein
howev
appear
close
involv
later
stage
inflammatori
respons
either
direct
activ
use
interferon
receptor
pathway
see
type
ifnmedi
transpresent
dendrit
cell
review
hwang
colleagu
two
main
cell
present
alveoli
type
type
pneumocyt
type
pneumocyt
larg
flatten
incap
replic
type
pneumocyt
smaller
respons
surfact
product
involv
antivir
defenc
mention
review
crouch
hillair
type
cell
damag
type
differenti
type
cell
diffus
alveolar
damag
pictur
seen
fatal
case
due
destruct
type
pneumocyt
consequ
disrupt
integr
vascularepitheli
interfac
lead
outpour
serum
protein
includ
albumin
lead
hyalin
membran
therefor
import
understand
whether
influenza
viru
target
mainli
type
type
epitheli
cell
van
riel
colleagu
perform
viru
bind
assay
demonstr
bound
type
cell
within
lung
type
cell
bind
season
corrobor
ex
vivo
infect
lung
tissu
demonstr
viral
egress
type
rather
type
cell
impli
destruct
type
cell
lead
diffus
alveolar
damag
might
due
direct
viral
cytopath
effect
may
secondari
cytokin
mediat
destruct
analysi
effect
laboratori
challeng
keep
isol
type
cell
nativ
state
difficult
rapidli
differenti
type
cell
though
mani
investig
use
cell
repres
lung
epithelium
cell
line
deriv
type
pneumocty
tumour
faith
repres
nonneoplast
counterpart
eg
lack
surfact
product
requir
trypsin
ad
effici
viru
replic
emerg
caus
great
deal
concern
compar
season
influenza
infect
significantli
high
morbid
mortal
question
clinician
research
whether
due
properti
new
viru
littl
human
immun
whether
intrins
viral
properti
result
high
mortal
infect
macrophag
epitheli
cell
vitro
set
point
latter
scenario
transcript
analysi
show
potent
season
influenza
product
inflammatori
cytokin
chemokin
influenza
encount
cell
pattern
recognit
receptor
prr
stimul
initi
antivir
respons
lead
product
interferon
cytokin
chemokin
three
main
pathway
trigger
lead
interferon
respons
toll
like
receptor
pathway
tlr
retino
acid
induc
gene
rigi
like
receptor
rlr
nucleotid
oligomer
domain
nod
like
receptor
pathway
pyrin
domain
contain
review
van
de
sandt
tlpr
present
cell
surfac
recogn
viral
surfac
glycoprotein
tlr
present
intracellularli
recogn
doubl
strand
viral
rna
dsrna
singl
strand
rna
viral
ssrna
respect
shinya
colleagu
previous
demonstr
prestimul
protect
effect
mice
challeng
hpai
protect
effect
also
seen
pretreat
lipopolysaccharid
lp
ligand
bind
result
activ
independ
pathway
one
involv
trif
pathway
also
requir
surfac
molecul
addit
studi
demonstr
cultur
lack
either
chang
replic
lp
stimul
interestingli
lp
alon
affect
express
interferon
stimul
gene
lead
upregul
express
antivir
molecul
found
upregul
pathway
thu
demonstr
suppress
infect
aid
synergist
upregul
find
interest
previous
thought
recogn
dsrna
mention
intracellular
receptor
recogn
ssrna
complex
degrad
endosom
though
play
import
role
innat
defenc
mechan
also
involv
antibodi
isotyp
switch
katz
colleagu
show
tlr
signal
involv
recruit
myeloidderiv
suppressor
cell
mdsc
play
role
format
humor
immun
respons
direct
acut
adapt
respons
toward
follow
influenza
viru
infect
nichol
jm
influenza
innat
immun
wwwicjournalorg
thu
appear
play
dual
role
recognit
vrna
earli
infect
term
immun
activ
mhc
class
ii
endocyt
pathway
backup
late
endosom
compart
pathway
recogn
vrna
cytosol
compon
rigi
nlr
number
good
review
articl
pathway
avail
pathway
exist
order
distinguish
host
self
rna
invad
pathogen
rna
ie
nonself
intracellular
detect
rna
ascrib
two
cytoplasm
helicas
call
rigi
melanoma
differentiationassoci
gene
product
rigi
consecut
caspas
activ
recruit
domain
card
central
helicas
domain
ctermin
domain
fig
knockout
studi
show
rigi
abl
discrimin
differ
strain
viru
rigi
ortho
paramyxo
rhabdovirus
picornavirus
note
third
member
rlr
pathway
lack
card
interact
motif
thought
act
posit
regul
make
viral
rna
complex
access
rigi
recognit
viral
rna
rigi
enhanc
ppp
present
rna
act
hook
remov
ppp
reduc
interferon
induct
triphosph
termin
vrna
recogn
rigi
complex
undergo
conform
chang
card
abl
ubiquitin
add
link
ubiquitin
chain
rigi
second
card
rigi
appear
crucial
effect
function
unlik
mani
result
ubiqutin
chang
rigi
lead
degrad
proteasom
actual
critic
step
subsequ
interact
rigi
mav
though
exact
mechan
facilit
clearli
understood
trim
protein
call
tripartit
motif
even
though
gene
encod
trim
describ
small
number
well
character
sinc
demonstr
gene
encod
trim
upregul
interferon
role
investig
mention
ubiquitin
activ
inhibit
stabil
inhibit
thu
affect
downstream
activ
pathway
viral
infect
card
express
ubiquitn
abl
interact
card
adaptor
protein
mitochondri
antivir
signal
mav
mitochondria
lead
activ
complex
downstream
complex
follow
transcript
type
interferon
end
result
activ
tlr
rigi
pathway
increas
transcript
cytokin
chemokin
interferon
recruit
neutrophil
activ
macrophag
lead
matur
dendrit
cell
influenza
infect
type
interferon
major
cytokin
limit
viral
replic
recruit
immun
cell
site
infect
produc
inflamm
interferon
act
receptor
present
cell
adjac
cell
activ
antivir
signal
cascad
includ
tyrosin
kinas
janu
kinas
phosphoryl
indu
transcript
hundr
gene
contain
interferon
stimul
respons
element
irs
review
van
de
sandt
ifn
stimul
gene
encod
trim
protein
plu
antivir
protein
mxa
viperin
tetherin
oa
one
protein
particular
pkr
involv
dsdna
bind
function
antivir
block
gener
translat
endotheli
cell
past
consid
collater
damag
process
dad
initi
loss
endotheli
integr
subsequ
microvascular
leakag
key
featur
bacteri
sepsi
viral
infect
pandem
autopsi
studi
demonstr
viral
antigen
endotheli
cell
demonstr
infect
may
explain
extrapulmonari
dissemin
viru
infect
also
shown
polar
endotheli
cell
infect
vitro
intriguingli
recent
public
shown
endotheli
cell
may
actual
involv
modul
innat
immun
respons
via
signal
metabolit
sphingolipid
ligand
gprotein
coupl
receptor
role
receptor
ligand
shown
marsolai
colleagu
use
sip
ligand
found
reduc
cytokin
respons
use
mous
adapt
influenza
viru
work
demonstr
level
express
lymphat
vascular
endotheli
cell
treatment
agonist
abl
reduc
product
chemokin
cell
decreas
ifn
secret
affect
thu
show
endotheli
cell
abl
actual
modul
inflammatori
respons
possibl
sip
analog
may
use
therapi
dampen
excess
innat
immun
respons
preced
discuss
indic
human
respiratori
tract
develop
complex
network
mechan
ensur
protect
effect
viral
infect
fact
sever
influenza
occur
lower
respiratori
tract
show
viru
evolv
mechan
circumv
protect
mechan
broadli
divid
surfac
protein
ha
ha
involv
extracellular
phase
exposur
environ
surfac
cell
viru
intracellular
environ
intern
gene
take
enhanc
replic
progeni
virion
regard
extacellular
compart
role
na
cleav
sialyl
mucin
glycosyl
ha
alreadi
discuss
within
cell
found
long
time
influenza
evolv
strategi
evad
power
ifn
defenc
mechan
garciasastr
colleagu
show
product
recombin
influenza
lack
gene
call
nonstructur
protein
abl
suppress
ifn
pathway
employ
strategi
mani
level
includ
target
rememb
requir
ubiqutin
activ
rigi
lead
subsequ
ifn
product
perform
function
need
oligomer
inhibit
abolish
activ
influenza
strain
interact
possibl
conserv
chang
may
affect
function
also
function
impair
interferon
induc
protein
pkr
recal
shut
translat
sustain
phosphoryl
translat
factor
thu
inhibit
viru
propag
final
distinct
featur
mani
avian
strain
includ
ctermin
glusergluv
esev
bind
motif
pdz
domain
mediat
protein
interact
find
identifi
largescal
sequenc
analysi
virus
isol
differ
bird
mammalian
speci
esev
domain
mainli
present
avian
influenza
virus
human
virus
conserv
rskv
domain
jackson
colleagu
use
revers
genet
insert
differ
motif
mous
adapt
found
rskv
better
surviv
lower
viral
load
esev
motif
later
studi
soubri
colleagu
use
lpai
ctermin
rskv
differ
speci
cell
anim
duck
mice
found
chang
replic
esev
rskv
speci
specif
particular
esev
induc
higher
level
ifn
rskv
mous
cell
eskv
less
sensit
type
interferon
pretreat
group
also
recent
studi
hpai
delet
amino
acid
present
recent
strain
affect
poultri
found
ctermin
esev
domain
increas
virul
delet
six
amino
acid
impact
viral
replic
immun
respons
note
viru
also
stop
codon
thu
suggest
behav
similar
six
amino
acid
delet
final
sinc
evid
sever
influenza
caus
certain
influenza
virus
trigger
exagger
innat
immun
respons
therapeut
option
addit
antivir
therapi
may
util
buy
time
acquir
immun
respons
take
use
immunmodulatori
agent
steroid
discourag
statin
therapi
advoc
number
individu
review
number
public
claim
evid
reduct
mortal
review
fedson
effect
viral
clearanc
infect
mice
one
research
group
use
palmidron
stimul
tcell
kill
infect
cell
inhibitor
shown
block
viru
propag
vitro
vivo
consequ
overproduct
cytokin
chemokin
lung
mice
infect
reil
sj
unpublish
observ
evid
role
ifn
antiinfluenza
viru
respons
shown
use
receptor
defici
mice
shown
effect
control
hepat
b
c
human
particularli
activ
hcv
cure
affect
individu
sar
outbreak
toronto
ifn
novel
synthet
consensu
ifn
show
clinic
benefit
patient
treat
steroid
ifn
compar
treat
steroid
alon
guinea
pig
ferret
infect
season
influenza
respect
ifn
treatment
result
reduc
viral
titr
improv
pulmonari
patholog
promis
result
intranas
administr
prevent
influenza
infect
sideeffect
prevent
widespread
adopt
rout
administr
treatment
human
ex
vivo
tissu
infect
show
abl
reduc
infect
ifn
treatment
postexposur
produc
less
dramat
effect
latter
scenario
one
like
encount
clinic
practic
impli
ifn
use
clinic
set
may
limit
benefit
event
new
pandem
sever
transmiss
similar
outbreak
limit
avail
antivir
agent
comprehens
understand
pathway
mechan
involv
innat
immun
antivir
respons
thu
necessari
addit
agent
may
use
control
viral
replic
spread
adequ
vaccin
avail
